Navigation Links
Jonathan Salkin Named Executive Vice President of Devicor Medical Products
Date:5/5/2009

Salkin joins former colleague Tom Daulton to provide strategic leadership as Devicor looks to make its first major acquisition

PLEASANT PRAIRIE, Wis., May 5 /PRNewswire/ -- Devicor Medical Products, LLC, today named Jonathan Salkin to serve as Executive Vice President, Corporate Development & Strategy. Salkin's most recent experience as a Managing Director at the Royal Bank of Scotland plc is highlighted by his successful launch of that Bank's first healthcare investment banking group globally. Prior to that, as Vice President of Corporate Development for Cardinal Health, Salkin was instrumental in strategic planning, mergers and acquisitions for Cardinal's $10 billion Medical Products & Services group.

It was at Cardinal that Salkin first connected with Tom Daulton, Devicor's CEO. "Jon brings the perfect blend of disciplines to Devicor," said Daulton. "His combined experience in the worlds of finance, strategy and healthcare will drive us forward as we work to build a market-leading medical device company."

Based in the New York City area, one of Salkin's primary responsibilities will be to work with Daulton to secure Devicor's initial platform acquisition as the company looks to acquire established interventional medical device businesses that manufacture and sell products to clinicians in settings such as hospitals, surgery centers, or physician offices. Beyond that, Salkin will work on strategic initiatives including subsequent mergers, acquisitions, and other collaborative endeavors; he is expected to take a leadership role in running certain segments of the day-to-day operations; and he'll serve on Devicor's Board of Directors.

"Having previously worked with Tom to successfully build a fast-growing, profitable business, I am thrilled to once again be his partner as Devicor deploys its substantial funding into products and companies that are advancing the field of interventional medicine and lowering overall healthcare costs," Salkin said.

Devicor was formed in partnership with GTCR, one of the nation's leading private equity firms, which plans to invest up to $250 million of equity capital to support the company's strategy.

Salkin previously worked for Dresdner Kleinwort Wasserstein (formerly Wasserstein Perella & Co.) as Director of Healthcare Mergers & Acquisitions, and in the Mergers, Acquisitions and Corporate Advisory Group at Deutsche Bank. He received a BA, MBA, and JD from Case Western Reserve University in Cleveland, Ohio.

About Devicor Medical Products, LLC

Devicor Medical Products, headquartered in Pleasant Prairie, Wisconsin, is a global medical device company focused on acquiring and developing clinical preference medical devices and companies. For more information, please visit www.devicormedical.com or call (262) 857-9300.

About GTCR

Founded in 1980, GTCR Golder Rauner, LLC is a leading private equity investment firm and long-term strategic partner for outstanding management teams. The Chicago-based firm pioneered the investment strategy of identifying and partnering with exceptional executives to acquire and build companies through a combination of acquisitions and strong internal growth. GTCR currently manages more than $8 billion of equity capital invested in a wide range of companies and industries. More information about GTCR can be found at www.gtcr.com.


'/>"/>
SOURCE Devicor Medical Products, LLC
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. Jonathan Finder, M.D., Joins Point Pleasant Pediatric Special Cares Medical Management Team as Pulmonary Consultant
2. Dr. Jonathan White Joins Haemonetics as Head of Research and Development
3. Emmy Winner Jonathan Jackson With Rock Band Enation Take On Predators & Rapists
4. Jonathan Jacobson Appointed General Manager, Global Business Strategies & Operations, Menicon Co., Ltd.
5. Jailed Indian Pediatrician Wins 2008 Jonathan Mann Award for Global Health and Human Rights
6. Pixantrone Now Available in Europe on a Named-Patient Basis
7. PartsSource Named Team NEO Winner for 2009
8. Junghans named PI in $5.9 million breast cancer grant
9. Aging Advocate Named President of Marylands Leading Long-Term Care Association
10. Fargo Named Americas Cleanest City in American Lung Associations State of the Air Report
11. Robert J. Gould Named President at Partnership for Prevention
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/27/2016)... ... June 27, 2016 , ... ... authorized OSHA Training Institute Education Center headquartered in Northern California, has issued an ... extreme heat at their worksites. Employers with workers exposed to high temperatures ...
(Date:6/27/2016)... ... ... "FCPX editors can now reveal their media with growing colorful split screen ... - CEO of Pixel Film Studios. , ProSlice Color brings the split screens ... reveal the media of their split screens with growing colorful panels. , ProSlice Color ...
(Date:6/27/2016)... ... , ... TherapySites, the leading website and online ... Counseling Association. This new relationship allows TherapySites to continue to extend their ... benefits and promotional offers. , "TCA is extremely excited about this new partnership, ...
(Date:6/27/2016)... ... June 27, 2016 , ... ... strategic partnership with Connance, a healthcare industry leader providing predictive analytics to ... technology combine to provide health systems, hospitals and ambulatory surgical centers with ...
(Date:6/27/2016)... ... 2016 , ... A revolution is underway. Brooklyn-based company, ... for the millions of people who require these medical transport services annually. ... the use of technology. Now, SmartEMS has put forth an industry-changing app that ...
Breaking Medicine News(10 mins):
(Date:6/26/2016)... One of Australia,s successful biotechnology ... a new biotechnology company, Noxopharm Limited [ABN 50 608 966 123] ... to list on the ASX. Noxopharm is a clinic-ready ... a Phase 1 clinical study later this year. ... the biggest problems facing cancer patients - the ability of cancers ...
(Date:6/26/2016)... Jazz Pharmaceuticals plc (Nasdaq: JAZZ ... Antitrust Improvements Act of 1976, as amended ("HSR"), with ... ("Celator"; Nasdaq: CPXX ) expired effective June ... As previously announced on May 31, 2016, Jazz ... under which Jazz Pharmaceuticals has commenced a tender offer ...
(Date:6/26/2016)... , June 27, 2016  VMS Rehab Systems, Inc. ... will take whatever measures required to build a strong ... which is currently listed on the OTC Markets-pink current ... Chairman and CEO, "We are seeing an anomaly in ... understand, not only by the Company, but shareholders and ...
Breaking Medicine Technology: